Cochlear Forecast, price target & analysts
Cochlear Target price 2025 - Analyst rating & recommendation
Cochlear Classifications & Recommendation:
Cochlear Price Target
| Target Price | A$303.67 |
| Price | A$288.60 |
| Potential |
5.22%
register free of charge
|
| Number of Estimates | 16 |
|
16 Analysts have issued a price target Cochlear 2026 .
The average Cochlear target price is A$303.67.
This is
5.22%
register free of charge
A$373.80
29.52%
register free of charge
A$281.30
2.53%
register free of charge
|
|
| A rating was issued by 19 analysts: 7 Analysts recommend Cochlear to buy, 10 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Cochlear stock has an average upside potential 2026 of
5.22%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2032
| Jun '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion A$ | 2.34 | 2.62 |
| 4.81% | 11.95% | |
| Net Margin | 16.60% | 17.39% |
| 4.00% | 4.77% |
17 Analysts have issued a sales forecast Cochlear 2026 . The average Cochlear sales estimate is
This results in the following potential growth metrics:
17 Cochlear Analysts have issued a net profit forecast 2026. The average Cochlear net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032
| Jun '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share A$ | 5.93 | 6.98 |
| 9.21% | 17.71% | |
| P/E | 41.61 | |
| EV/Sales | 7.25 |
17 Analysts have issued a Cochlear forecast for earnings per share. The average Cochlear EPS is
This results in the following potential growth metrics and future valuations:
Current Cochlear Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JEFFERIES |
Locked
➜
Locked
|
Locked | Sep 08 2025 |
| MACQUARIE RESEARCH |
Locked
➜
Locked
|
Locked | Aug 21 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Jul 17 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Jul 16 2025 |
| MACQUARIE RESEARCH |
Locked
➜
Locked
|
Locked | Jul 16 2025 |
| MACQUARIE RESEARCH |
Locked
➜
Locked
|
Locked | Jul 15 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Apr 08 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Sep 08 2025 |
|
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
|
Aug 21 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Jul 17 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Jul 16 2025 |
|
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
|
Jul 16 2025 |
|
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
|
Jul 15 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Apr 08 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
